World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
84
Citations
48672
World Ranking
14818
National Ranking
37

Overview

Itamar Raz is affiliated with the Hebrew University of Jerusalem in Israel and has contributed extensively to the field of medical research, particularly focusing on endocrinology, diabetes, and metabolism. Their body of work spans a wide range of topics within medicine, with a principal emphasis on diabetes treatment and management.

Their research covers several interconnected areas, including:

  • Diabetes Treatment and Management
  • Metabolism, Diabetes, and Cancer
  • Pancreatic function and diabetes
  • Diabetes Management and Research
  • Diabetes and associated disorders
  • Chronic Kidney Disease and Diabetes
  • Diabetes, Cardiovascular Risks, and Lipoproteins

Itamar Raz has co-authored numerous publications with several frequent collaborators. These include:

  • Marc S. Sabatine
  • Ofri Mosenzon
  • Deepak L. Bhatt
  • Lawrence A. Leiter
  • Avivit Cahn

The scientist's work appears consistently in reputable journals, indicating a focus on cardiovascular and diabetes-related research. Their most frequent publication venues are:

  • Circulation
  • Journal of the American College of Cardiology
  • Diabetes Research and Clinical Practice
  • Diabetes Care
  • Diabetes/Metabolism Research and Reviews

Their research spans the broader field of Medicine, with notable emphasis on specific subfields such as:

  • Endocrinology, Diabetes and Metabolism
  • Molecular Biology
  • Surgery
  • Cardiology and Cardiovascular Medicine
  • Nephrology

Among the recent scientific publications associated with Itamar Raz are:

  • Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus, 2020, Circulation
  • Adolescent Obesity and Early-Onset Type 2 Diabetes, 2020, Diabetes Care
  • Overview of oxidative stress and inflammation in diabetes, 2024, Journal of Diabetes
  • A meta-analysis of GFR slope as a surrogate endpoint for kidney failure, 2023, Nature Medicine
  • Prediction of progression from pre-diabetes to diabetes: Development and validation of a machine learning model, 2020, Diabetes/Metabolism Research and Reviews

Best Publications

  • Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes

    Edmond J Lewis;Lawrence G Hunsicker;William R Clarke;Tomas Berl

  • Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus

    Benjamin M. Scirica;Deepak L. Bhatt;Deepak L. Bhatt;Eugene Braunwald;P. Gabriel Steg

  • SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.

    Thomas A Zelniker;Stephen D Wiviott;Itamar Raz;Kyungah Im

  • Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).

    Lars Rydén;Eberhard Standl;Małgorzata Bartnik;Greet Van den Berghe

  • Type 2 diabetes mellitus.

    Ralph A. DeFronzo;Ele Ferrannini;Leif Groop;Robert R. Henry

  • Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ

    F. Zurlo;S. Lillioja;A. Esposito del Puente;B. L. Nyomba

  • Oral Treatment With α-Lipoic Acid Improves Symptomatic Diabetic Polyneuropathy The SYDNEY 2 trial

    Dan Ziegler;Alexander Ametov;Alexey Barinov;Peter J. Dyck

  • Heart Failure, Saxagliptin and Diabetes Mellitus: Observations from the SAVOR - TIMI 53 Randomized Trial

    Benjamin M. Scirica;Eugene Braunwald;Itamar Raz;Matthew A. Cavender

  • β-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial

    Itamar Raz;Dana Elias;Ann Avron;Merana Tamir

  • Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus.

    Thomas A. Zelniker;Stephen D. Wiviott;Itamar Raz;KyungAh Im

  • Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE-TIMI 58 randomised trial.

    Ofri Mosenzon;Stephen D Wiviott;Avivit Cahn;Aliza Rozenberg

  • Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus.

    Eri T. Kato;Michael G. Silverman;Ofri Mosenzon;Thomas A. Zelniker

  • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy

    Tomas Berl;Lawrence G. Hunsicker;Julia B. Lewis;Marc A. Pfeffer

  • Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial.

    Itamar Raz;Peter W.F. Wilson;Krzysztof Strojek;Irina Kowalska

  • Impact of Achieved Blood Pressure on Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial

    Tomas Berl;Lawrence G. Hunsicker;Julia B. Lewis;Marc A. Pfeffer

  • Insulin resistance associated with lower rates of weight gain in Pima Indians

    Boyd A Swinburn;Bulangu L Nyomba;Mohammad F Saad;Francesco Zurlo

  • Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors’ Expert Forum

    William T. Cefalu;Sanjay Kaul;Hertzel C. Gerstein;Rury R. Holman

  • Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial.

    Thomas A. Zelniker;Thomas A. Zelniker;Marc P. Bonaca;Marc P. Bonaca;Remo H.M. Furtado;Remo H.M. Furtado;Ofri Mosenzon

  • Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus.

    Allison S. Kennington;Cynthia R. Hill;James Craig;Clifton Bogardus

  • Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction.

    Remo H.M. Furtado;Remo H.M. Furtado;Marc P. Bonaca;Itamar Raz;Thomas A. Zelniker

Frequent Co-Authors

Deepak L. Bhatt
Deepak L. Bhatt Mount Sinai Hospital
Marc S. Sabatine
Marc S. Sabatine Brigham and Women's Hospital
Darren K. McGuire
Darren K. McGuire The University of Texas Southwestern Medical Center
Stephen D. Wiviott
Stephen D. Wiviott Brigham and Women's Hospital
John P.H. Wilding
John P.H. Wilding University of Liverpool
Eugene Braunwald
Eugene Braunwald Harvard Medical School
Lawrence A. Leiter
Lawrence A. Leiter University of Toronto
Sabina A. Murphy
Sabina A. Murphy Brigham and Women's Hospital
Stefano Del Prato
Stefano Del Prato University of Pisa
Allan Flyvbjerg
Allan Flyvbjerg Steno Diabetes Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in medicine but aren’t sure about pursuing a full MD, there are several rewarding healthcare career pathways available online. Many students start by exploring the best online schools for high school students who wish to gain early exposure to health sciences before committing to further study.

For those looking to enter the workforce quickly, an increasingly popular route is earning a medical coding certification online. This program prepares students for administrative roles in clinics, hospitals, or insurance companies with the flexibility of remote learning.

Nursing remains one of the most sought-after professions, and affordable online pathways are now widely available. Prospective advanced practice nurses can consider cheap online fnp programs, enabling them to become Family Nurse Practitioners and provide primary care across communities.

For those at the beginning of their nursing journey, there are comprehensive online nursing programs that offer flexible study options for aspiring RNs and LPNs. These diverse degree and certification options provide practical, affordable pathways into the healthcare field beyond traditional medical school.

Best Scientists Citing Itamar Raz

Trending Scientists